EdgarLookup
POS AM

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1

Company
Sofgen Pharma S.A.
Filed
May 4, 2022
Accession Number
0001213900-22-023796
View Document ↗ View on SEC.gov ↗